- Home
- HCM vs DSC Comparison
HCM vs DSC Comparison
Compare HCM & DSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$11.01
N/A
Current Price
$5.72
Company Overview
Basic Information| Metric | HCM | DSC |
|---|---|---|
| Founded | 2000 | N/A |
| Country | Hong Kong | China |
| Employees | 1796 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | N/A | 2026 |
Fundamental Metrics
Financial Performance| Metric | HCM | DSC |
|---|---|---|
| Price | $11.01 | $5.72 |
| Analyst Decision | Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | 50.9K | ★ 99.7K |
| Earning Date | 03-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.60 | N/A |
| Revenue Next Year | $15.62 | N/A |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.77 | $4.52 |
| 52 Week High | $19.50 | $8.93 |
Technical Indicators
Market Signals| Indicator | HCM | DSC |
|---|---|---|
| Relative Strength Index (RSI) | 47.58 | 50.13 |
| Support Level | $10.83 | $4.69 |
| Resistance Level | $11.80 | $6.15 |
| Average True Range (ATR) | 0.23 | 0.93 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 16.67 | 26.50 |
Price Performance
Historical Comparison HCM
DSC
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.